Idorsia Pharmaceuticals
The purpose of Idorsia is to discover, develop, and commercialize innovative medicines to help more patients. We have more ideas, we see more opportunities, and we want to transform the horizon of therapeutic options. Idorsia US was established in 2020 to drive the company into a new phase and realize our ambition of bringing innovative medicines from bench to bedside. With commercial operations based outside of Philadelphia, PA, one of densest communities of life sciences talent in the world, our goal is to build the commercial footprint that will deliver Idorsia’s deep pipeline of products from its drug discovery engine to the US market – changing the lives of many patients. We have assembled a diverse and highly regarded leadership team, with decades of experience across therapeutic areas.
100 Matsonford Road, Suite 101
Radnor, PA 19087
Stock Symbol: IDIA
Stock Exchange: SIX Swiss Exchange
Our people are our most important asset, and fully leveraging their potential is critical to our success. We want them to feel proud of their work and the company they work for. Our future as a company depends on a workplace that enables employees to achieve their full potential – both at work and outside the office. It’s the Idorsia team’s passion for science that will translate our objectives into value creation for all our stakeholders. We are doing more with less in a highly productive environment where people enjoy their work. Our Idorsia professionals show up with energy, intellect, and creativity.
Idorsia is a company with a culture that fosters innovation and science, while putting patients in the center. Idorsia seeks to make discoveries that bring profound value to society and satisfy unmet medical needs. If you identify with Idorsia’s culture please review our current job openings and submit your application.
